Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001289234 | SCV001476917 | uncertain significance | not provided | 2020-03-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001289234 | SCV001826767 | uncertain significance | not provided | 2020-08-19 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function |
Labcorp Genetics |
RCV001289234 | SCV002189918 | likely benign | not provided | 2024-10-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035568 | SCV004946094 | uncertain significance | Inborn genetic diseases | 2021-12-03 | criteria provided, single submitter | clinical testing | The c.1888G>A (p.V630I) alteration is located in exon 13 (coding exon 12) of the SCNN1B gene. This alteration results from a G to A substitution at nucleotide position 1888, causing the valine (V) at amino acid position 630 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |